BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 25, 2004
View Archived Issues
Glufast launched in Japan
Read More
Prostaglandins suggested as a potential target in ulcerative colitis
Read More
Alvimopan improves gastrointestinal transit in POI and chronic constipation
Read More
Immunological changes induced by glatiramer acetate in an experimental colitis model
Read More
FK-778 results presented at American transplantation congress
Read More
Levetiracetam: advantageous treatment for seizures after liver transplantation
Read More
ISA-247 more potent than ciclosporin in renal transplant recipients
Read More
Valganciclovir simple, effective as CMV prophylaxis in renal transplantation
Read More
Alemtuzumab use may reduce tacrolimus toxicity in liver transplantation
Read More
Enrollment completed in phase III trial of enoximone
Read More
ProMetic achieves second milestone in AM-Pharma agreement
Read More
Biomira and Inno-centre Alberta to create spin-off company to develop L-IL-2 technology
Read More
Favrille receives SPA from FDA for FavID
Read More
FDA approves Taxotere for treatment of prostate cancer
Read More
MorphoSys and Novartis to discover and develop antibody-based therapeutic agents
Read More
Avelox approved for treatment of CAP caused by multidrug resistant S. pneumoniae
Read More
Zimycan receives approval in Belgium for treatment of diaper dermatitis
Read More
Phase 2 Discovery receives positive results from phase II trial with PD-6735
Read More
Enzo Biochem to begin phase I trial of EGS-21
Read More
Positive data reported from phase IIIb Xyrem study
Read More
Duloxetine may be safe and effective for diabetic neuropathic pain
Read More
Ziconotide could be safe and effective in malignant and nonmalignant pain
Read More
Enrollment commences in phase III Altropane trial
Read More
CRADA to develop stem cell technology for cardiovascular disease treatment
Read More
Onco TCS NDA accepted for review
Read More
inGenium aids Peregrine's development of monoclonal antibody for lymphoma
Read More
Yamanouchi presents activators of PGC-1 and mtTFA genes and their therapeutic use
Read More
New antidepressant agents with 5-HT reuptake, H1 and 5-HT2 blocking activity
Read More
Novel PDE4 inhibitors and their use covered by Takeda patent
Read More
Gruenenthal scientists design novel NOS inhibitors
Read More
New interferon inducers for topical application designed at Sumitomo
Read More
New stilbene-based immunomodulators prepared and tested at Welichem
Read More
New neurotrophic agents and their use in Parkinson's disease, ALS, stroke, etc.
Read More
Activity of LBM-415 extensively investigated
Read More